Evaluation of Oral Alpha-Cyclodextrin for Decreasing Serum Cholesterol

NCT01131299 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

103

Enrollment

NIH

Sponsor class

Conditions

Cardiovascular Disease

Interventions

OTHER: Placebo
DRUG: Alpha cyclodextrin

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)